9H-Purin-2-amine, N-[(4-methoxyphenyl)diphenylmethyl]-9-[(1S,3R,4S)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-6-(phenylmethoxy)-(CAS: 142217-80-9)

This compound is subject to various regulatory guidelines including GHS classification for hazardous materials, REACH regulations for registration, evaluation, authorization, and restriction of chemicals, and FDA/EPA requirements for safety and environmental protection. Specific handling and disposal guidelines must be followed to ensure compliance with local and international regulations.

Common alternatives to this compound in synthesis include analogous purine derivatives or simpler purine analogs. Substitutes like other purine-based compounds or their isomers can serve as viable alternatives, depending on the specific application requirements.

The market for this compound is driven by its use in pharmaceutical research, particularly in the development of targeted drug therapies. Research trends indicate an increasing focus on purine-based compounds for their potential in treating various diseases, including cancer and metabolic disorders. Market demand is expected to grow due to these advancements.

Waste containing this compound should be collected in a sealed, leak-proof container and handled according to the specific waste disposal guidelines for hazardous materials. Proper incineration or professional waste disposal services should be utilized to ensure environmental protection and safety. Disposal methods should comply with local and international regulations to prevent pollution and ensure worker safety.